How compassionate use enabled Israel to deliver the Pfizer-BioNTech COVID-19 vaccination to vulnerable children aged 12–15 years before regulatory approval

the Israeli Pediatric Association Task Force

    Research output: Contribution to journal › Article › peer-review

    Fingerprint

    Dive into the research topics of 'How compassionate use enabled Israel to deliver the Pfizer-BioNTech COVID-19 vaccination to vulnerable children aged 12–15 years before regulatory approval'. Together they form a unique fingerprint.

    Medicine & Life Sciences